Shots:

• The Defeat-NCD Partnership and BI partnered to address the access to healthcare issues related to NCDs by helping governments to strengthen national institutions- scaling up community-based health services and expanding the accessible range of medicines and healthcare solutions
• The focus of the collaboration is to tackle premature death- sickness- disability- and associated social and economic impacts from NCDs in low resources countries
• BI’s portfolio contains 85% therapies targeting NCD and with its Access to Healthcare strategy- based on the three strategic pillars Availability- Innovative Solutions and Sustainable Models to explore & evaluate a holistic approach for broadening healthcare access in underserved communities and countries

Click here to­ read full press release/ article | Ref: Boehringer Ingelheim | Image: WestFair